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Abstract
National and international guidelines on the treatment of attention deficit hyperactivity disorder (ADHD) in children and 
adolescents call for annual reviews to assess continuing need for medication by considering brief periods without medication, 
referred to as ‘Drug holidays’. However, drug holidays are reactively initiated by families, or recommended by practitioners 
if growth has been suppressed by medication rather than proactively to check the need. There is little evidence of planned, 
practitioner-initiated drug holidays from methylphenidate. The aim of this study was to identify what stops practitioners 
from routinely discussing planned drug holidays from methylphenidate with children, adolescents, and their parents. Prac-
titioners involved in shared-care prescribing for children and adolescents with ADHD in one UK County were included. 
Interviews with 8 general practitioners (GPs) and 8 Child and Adolescent Mental Health Service (CAMHS) practitioners 
were conducted. Transcripts were analysed qualitatively against the components of the Capability–Opportunity–Motiva-
tion–Behaviour (COM-B) model. Possible interventions for increasing prescribers’ engagement with planned drug holidays 
were considered in response. Multiple barriers to practitioner engagement in planned drug holidays from methylphenidate 
were identified. Capability, in terms of knowledge and skills, was not a barrier identified for CAMHS practitioners but was 
for GPs. Opportunity was a main barrier for both groups, who reported lack of time and the absence of educational mate-
rial about drug holidays. Motivation was more complex to define, with CAMHS practitioners questioning the need for drug 
holidays and GPs being more accepting due to worries about long-term medication side effects as well as cost savings. ‘Edu-
cation’ and ‘enablement’ interventions were identified as key activities targeting all three components, which could feasibly 
increase uptake of practitioner-initiated planned drug holidays from methylphenidate. The application of the COM-B system 
identified a number of key barriers to practitioner engagement with drug holidays in children and adolescents with ADHD. 
Accordingly, a number of interventions could be developed to facilitate change. For example, educating and training GPs 
about ADHD management and drug holidays, and developing a decision aid to help families make informed decisions about 
whether or not to implement drug holidays could be used.
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Background
Attention deficit hyperactivity disorder (ADHD) is char-
acterised by hyperactivity/impulsivity and inattention, 
affecting around 5% of school-age children in the UK 
(NICE 2013). The diagnosis of ADHD is characterised 
by symptoms such as hyperactivity, inability to concen-
trate for a length of time, bad temper, problems complet-
ing tasks, organisation difficulties, and impulsivity (Kidd 
2000). The condition is associated with many potential 
medical, emotional, behavioural, social, and academic 
consequences (NICE 2006). Most children are first diag-
nosed with ADHD when they enter school (Sax and Kautz 
2003) with about three-quarters of those diagnosed being 
male (Schneider and Eisenberg 2006).
The treatment of ADHD involves multiple components 
including medical, behavioural, and educational interven-
tions. Medication is the first-line treatment for school-aged 
children and young people with ADHD who have severe 
symptoms and impairment, and the second line for mod-
erate impairment (NICE 2013). Worldwide, studies have 
shown that ADHD medications (both stimulants and non-
stimulants) are effective in reducing ADHD symptoms 
and enhancing academic functioning in children receiv-
ing treatment (Hechtman et al. 2004; Pietrzak et al. 2006; 
Wilson et al. 2006). However, there has been a debate 
about the long-term side effects versus advantages on 
child’s schoolwork and achievement with ADHD medica-
tions (Sharpe 2014). An 8-year prospective follow-up of 
children treated for ADHD in a multisite study (MTA—
Multimodal Treatment of Attention Deficit Hyperactivity 
Disorder) showed no long-term advantage of medication 
beyond 2 years in most cases (Molina et al. 2009). Plus, 
the short-term adverse effects such as suppression of appe-
tite and growth in children and problems with sleeping 
present legitimate concerns for some families (Zachor 
et al. 2006; Faraone et al. 2008).
Whereas some parents tend to continue giving their 
children medication on a long-term basis, in a process 
described as ‘doing what helps most’ (Cormier 2012), oth-
ers allow breaks from medication on some days (mostly 
non-school days), known as ‘drug holidays’ (Wilens et al. 
2005; Hugtenburg et al. 2005; Dosreis et al. 2003). Drug 
holidays are ‘deliberate interruption of pharmacotherapy 
for a defined period of time and for a specific clinical pur-
pose’; in ADHD practised mostly on non-school days such 
as weekend and/or school holidays (Howland 2009). When 
a drug holiday is being considered in ADHD, it typically 
concerns treatment with stimulant medications not atom-
oxetine or the alpha 2-agonists (Weed 2016). A qualita-
tive study identified two types of practices: families who 
follow the ‘school-time medication pattern’ where they 
medicate their children only during the school week; and 
those who follow ‘all-time medication pattern’ where they 
give their children the medication every day, all the time 
(Kinda et al. 2016). There are seasonal patterns associ-
ated with using stimulant medication that coincide with 
school holidays (Shyu et al. 2016; Cascade et al. 2008). 
A systematic literature review found that between 25 and 
70% of families follow the school-time medication pat-
tern (Ibrahim and Donyai 2015). Different factors have 
been reported to affect the pattern adopted by families 
such as parents’ ability to cope with the child’s behaviour, 
the child’s academic progress, the location of the child’s 
problematic behaviour, severity of symptoms, and parental 
beliefs about the medication (Kinda et al. 2016).
The systematic literature review identified four benefits 
from practising drug holidays from ADHD medication 
including: assessing the need for medication, managing and 
preventing medication side effects, managing drug tolerance 
(the need to increase the dose with time to obtain the same 
therapeutic effect), and negotiating medication continuation 
or discontinuation (Ibrahim and Donyai 2015). The review 
suggested that doctors should discuss planned drug holidays 
with some if not all families at some point in the treatment of 
the child as a positive approach. Longer breaks from ADHD 
medication were reported to enable child growth, while 
shorter breaks could reduce insomnia and improve appe-
tite. The Institute of Clinical Systems Improvement (ICSI) 
recommends that linear growth impairment as a result of 
ADHD treatment might be managed by limiting stimulant 
to high-priority needs, for example by trying weekend or 
vacation ‘drug holidays’ (ICSI 2010). Similarly, the Euro-
pean clinical guidelines for hyperkinetic disorder state, ‘If 
there are indications of growth retardation, drug holidays 
(e.g. during the summer vacation) are recommended’ (Tay-
lor et al. 2004).
In addition, the National Institute for Health and Care 
Excellence (NICE) guidelines in the UK and guidance by 
the American Academy of Child and Adolescent Psychi-
atry (AACAP) in the USA make reference to intentional 
drug holidays in ADHD (NICE 2013; AACAP 2007). The 
AACAP guidelines suggest that clinicians should discuss the 
continuing need for medication with families if the patient 
with ADHD has been free of symptoms for at least 1 year. 
However, NICE recommendations about planned breaks 
from medication in children with ADHD and their families 
are less direct, stating ‘effect of missed doses, planned dose 
reductions and brief periods of no treatment should be taken 
into account and the preferred pattern of use should also 
be reviewed’. Nationally, and certainly within the setting of 
this study, methylphenidate shared-care arrangements ask 
both CAMHS doctors and general practitioners to discuss 
a 2-week drug holiday after 2 years of stimulant use to test 
the continuing need for treatment. This protocol is necessary 
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for CAMHS to get the payment from the Commissioning 
for Quality and Innovation (CQUIN) in primary care. The 
system was introduced in 2009 to make a proportion of 
health care providers’ income conditional on demonstrating 
improvements in quality and innovation in specified areas of 
patient care. Shared-care is a particular arrangement which 
allows the transfer of clinical responsibility from a specialist 
service (e.g. CAMHS) to general practice, where prescrib-
ing by the GP is supported by a shared-care arrangement 
(NHS 2018).
Despite the national and international recommendations 
and the evidence of possible benefits from planned drug 
holidays, most planned drug holidays seem to be initiated by 
parents (Kinda et al. 2016; Ibrahim and Donyai 2015; Brink-
man et al. 2009). Only 30 and 60% of practitioners in the 
USA and the UK, respectively, would consider discussing 
breaks from medication annually with families of children 
with ADHD (Salmon and Kemp 2002; Stockl et al. 2002). 
Therefore, the purpose of this study was to explore and iden-
tify the barriers for practitioners in a UK setting to discuss 
and undertake formal planned drug holidays from ADHD 
medication with a focus on testing the continuing need for 
medication. Identifying these barriers could possibly inform 
the selection of suitable interventions to increase the imple-
mentation of planned drug holidays under the supervision 
of health expertise.
Methods
Design
This was a qualitative research study utilising individual 
interviews. Transcripts were analysed thematically (Sad-
ler et  al. 2010) against the components of the Capabil-
ity–Opportunity–Motivation–Behaviour (COM-B) model 
(Michie et al. 2011), to identify barriers to the uptake of 
planned drug holidays by practitioners. This approach was 
taken because it can provide a systematic way to move 
from behavioural analysis to identifying potential interven-
tions which might bring about change. The COM-B system 
explains that human behaviour is best understood through 
the interaction between three main components: capability 
(physical and psychological), opportunity (social and physi-
cal), and motivation (reflective and automatic) (Michie et al. 
2011) (see Table 1).
The Chair of the South Central, Berkshire NHS Research 
Ethics Committee (REC) advised that the research did not 
require NHS REC review because it involved interviews 
with NHS staff and not patients. The study was reviewed 
and approved by the University of Reading REC (reference 
UREC 12/18), the Berkshire NHS Research & Development 
office (letter of access granted 22/06/2012) and the Thames 
Valley Primary Care Research Partnership (reference TV84).
Sample
Sixteen health care practitioners were purposefully sampled 
and contacted. The goal of purposeful sampling as described 
by Bryman (2012) is ‘to sample cases/participants in a stra-
tegic way’. Prescribing stimulants (e.g. methylphenidate) 
and other ADHD medications for children and adolescents 
is governed by shared-care arrangements between primary- 
and secondary-care professionals in the locality of this 
research (a UK county), where an annual discussion of a 
2-week drug holiday is recommended. Therefore, the sam-
ple compromised of Child and Adolescent Mental Health 
Services (CAMHS) practitioners and general practitioners 
(GPs) in the study setting who responded to the invitation 
letter. Participants were recruited until no more new and sig-
nificant concepts emerged (i.e. sampling saturation) (Fusch 
and Ness 2015). Data saturation was achieved by constantly 
comparing transcripts and checking whether any new data or 
concepts emerged. According to the literature in qualitative 
research, a total of 16 participants were considered suffi-
cient (Boddy 2016). CAMHS practitioners were approached 
via a mutual resource (a CAMHS specialist consultant) 
who emailed an invitation letter and information sheet to 
all practitioners within a community and mental health 
hospital trust. Eight CAMHS practitioners (five female, 
three male) from four NHS CAMHS clinics across four 
towns took part in the study. These practitioners see simi-
lar patients and receive referrals according to their locality. 
GPs were recruited via an invitation letter and information 
Table 1  Description and definition of the COM-B components
COM-B components Definition
Capability Physical psychological Capability refers to an individual’s psychological and physical ability to get involved in the 
specific activity under concern and it includes having the knowledge and skills necessary to 
engage in the activity
Opportunity Physical social Opportunity is the different external factors that make the behaviour possible or prompt it. 
Opportunity barriers are external constraints on a provider’s enactment of a behaviour
Motivation Reflective automatic Motivation is defined as the brain processes that boost and direct behaviour including: habitual 
processes, emotional response, as well as analytical decision making
 K. Ibrahim, P. Donyai 
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sheet posted to 150 GPs selected at random from publicly 
available NHS addresses in the same county. Six GPs agreed 
to take part in the study. The ‘snowball’ technique was also 
used to recruit a further two GPs (Sadler et al. 2010) via the 
already-recruited GP participants. Eight GPs (two female, 
six male) from six different practices across four towns took 
part in the study.
Procedure
Semi-structured interviews were conducted with the 16 prac-
titioners using an interview schedule focusing on explor-
ing beliefs about medication and personal experiences with 
ADHD drug holidays (see additional file 1). The semi-struc-
tured interview guide was drafted and refined by agreement 
with an external CAMHS consultant before being piloted 
with three volunteer participants to ensure workability and 
feasibility of the questions. The interview guide used open 
ended questions allowing flexibility to probe and ask ques-
tions in response to the conversation. Written consent was 
obtained from each participant before the interview, which 
was always held in a private office in the participant’s 
workplace. Interviews averaged approximately 20  min 
(ranged 10–30 min) in duration with GPs and 40 min (range 
30–47 min) with CAMHS practitioners.
Analysis
All interviews were audio-recorded, transcribed verbatim, 
and then anonymised. Data were analysed independently by 
the authors using the COM-B model as a basis following the 
steps of thematic analysis (Braun and Clarke 2006). Analysis 
involved a number of phases: familiarisation with the data, 
coding, searching for themes, reviewing themes, defining 
and naming themes, and writing up. After familiarising with 
data, the authors independently coded the data from each 
transcript and assigned initial ‘code names’. The researchers 
then compared their coding and resolved discrepancies by 
discussion. After agreement had been reached, the identi-
fied and named codes were allocated to match the COM-B 
components. This required the researchers to re-read data 
within the codes and then allocate the codes to the appro-
priate components. Data were imported into NVivo 10 to 
facilitate data analysis and code grouping.
The trustworthiness of the findings was established by 
‘member checking’. First, each participant was sent the tran-
script of their own interview to ensure its accuracy, and very 
minimal revisions were needed. Secondly, a detailed report 
of the main findings was sent out to all participants asking 
for their feedback. Six responses were received, and partici-
pants appeared to agree with the main findings of the study. 
In addition, the study findings were presented to a panel of 
12 CAMHS practitioners in the study county in one of their 
monthly meetings. There was a general agreement about the 
validity of the results in explaining the real practice of medi-
cation use and the exercise of planned drug holidays from 
ADHD medication among children and adolescents.
Results
The analysis of in-depth interviews using the COM-B sys-
tem unveiled a diverse range of practitioner experiences with 
ADHD medications and the barriers to discussing/initiating 
drug holidays in children and adolescents with ADHD to test 
the continued need for medication (see Table 2).
Identifying barriers to practitioner‑initiated 
planned drug holidays
1. Capability
Practitioners’ self-assessment of their capability to dis-
cuss and initiate a break without ADHD medication in chil-
dren and adolescents varied according to specialty. CAMHS 
practitioners had the necessary knowledge and skills to dis-
cuss and implement formal drug holidays with families. 
They were aware that they need to have formal discussions 
on an annual basis to check the continued need for medica-
tion, and that this was necessary for them to receive pay-
ment from the Commissioning for Quality and Innovation 
(CQUIN) in the Primary Care Trust. However, this did not 
appear to impact on their actual practice of initiating drug 
holidays themselves. Two CAMHS practitioners described 
that unintentional break from medication reported by par-
ents was documented by CAMHS practitioners as effective 
trials without medication when filling the CQUIN form as 
shown below:
So quite often I will find that I’m recording in the file 
that there was an effective trial off medication even 
though it wasn’t planned (CAMHS 8)
So it’s unusual situation where people have been asked 
to do this but certainly in my mind, when we did the 
CQUIN for a whole year and nobody wanted to stop 
the medication (CAMHS 2).
On the other hand, most GPs were unfamiliar with the 
specific recommendations about planned drug holidays. 
Lack of awareness of guidelines was assigned to differ-
ent reasons such as: difficulties accessing guidelines and 
shared-care protocols, and general work pressure and docu-
ment overload. GPs thought they lacked skills in relation 
to ADHD management and were not prepared to initiate 
a break from medication without specialist involvement, 
What stops practitioners discussing medication breaks in children and adolescents with ADHD?…
1 3
Ta
bl
e 
2 
 M
ap
pi
ng
 of
 be
ha
vi
ou
r c
ha
ng
e b
ar
rie
rs 
fo
r p
ra
cti
tio
ne
r-i
ni
tia
ted
 dr
ug
 ho
lid
ay
s t
o t
he
or
eti
ca
l c
on
str
uc
ts
CO
M
-B
 sy
ste
m
 co
m
po
ne
nt
s
Ba
rri
er
s f
or
 C
AM
HS
 to
 di
sc
us
s a
nd
 un
de
rta
ke
 dr
ug
 ho
lid
ay
s
Ba
rri
er
s f
or
 G
Ps
 to
 di
sc
us
s a
nd
 un
de
rta
ke
 dr
ug
 ho
lid
ay
s
Ph
ys
ica
l c
ap
ab
ili
ty
N/
A
La
ck
 of
 sk
ill
s a
nd
 tr
ain
in
g a
bo
ut
 A
DH
D 
an
d 
dr
ug
 h
oli
da
ys
W
e l
ea
rn
t a
bo
ut
 th
is 
wh
en
 w
e w
er
e a
t m
ed
ica
l s
ch
oo
l, 
an
d p
ick
 up
 bi
ts 
an
d b
ob
s 
fro
m
 re
ad
in
g, 
bu
t r
ea
l k
no
wl
ed
ge
 N
o, 
we
 ha
ve
n’t
, n
o. 
(G
P 
1)
I s
us
pe
ct 
m
os
t G
Ps
 ar
e n
ot
 pa
rti
cu
lar
ly
 sk
ill
s a
t A
DH
D.
 I 
do
n’t
 fe
el 
sk
ill
ed
 at
 it
 
(G
P6
)
‘w
e o
ug
ht
 to
 ha
ve
 tr
ain
in
g s
es
sio
ns
 on
, w
e’r
e t
alk
in
g a
bo
ut
 ho
lid
ay
s a
nd
 w
he
n t
o 
sto
p a
nd
 w
he
n, 
so
 w
e c
an
 ac
tu
all
y j
us
tif
y w
ith
 ev
id
en
ce
 w
ha
t w
e’r
e d
oi
ng
 (G
P 
2)
’
Ps
yc
ho
lo
gi
ca
l c
ap
ab
ili
ty
N/
A
Un
fa
m
ili
ar
ity
 w
ith
 gu
id
eli
ne
s’ 
an
d 
di
ffi
cu
lti
es
 ac
ce
ssi
ng
 th
em
No
, I
 th
in
k p
er
ha
ps
 th
at 
it 
wo
ul
d b
e u
se
fu
l f
or
 G
Ps
 to
 be
 m
or
e a
wa
re
 of
 th
e 
gu
id
eli
ne
s o
r t
o h
av
e t
he
 ri
gh
t g
ui
de
lin
es
 m
or
e e
as
ily
 av
ail
ab
le.
 W
ell
, t
he
y 
pr
ob
ab
ly
 ar
e b
ut
 it
’s 
ju
st 
kn
ow
in
g w
he
re
 to
 fi
nd
 th
em
 be
ca
us
e w
e g
et 
se
nt
 so
 
m
an
y b
its
 of
 in
fo
rm
ati
on
 th
at 
it,
 it
’s 
a c
on
sta
nt
 th
in
g (
GP
5)
So
cia
l o
pp
or
tu
ni
ty
Pa
re
nt
s’ 
re
jec
tio
n 
to
 co
ns
id
er
 b
re
ak
s f
ro
m
 m
ed
ica
tio
n 
du
e t
o c
on
ce
rn
s 
ab
ou
t i
nt
er
ru
pt
in
g t
he
 tr
ea
tm
en
t
M
os
t o
f t
he
 pa
re
nt
s d
on
’t 
wa
nt
 to
 st
op
 m
ed
ica
tio
n…
Do
 yo
u w
an
t t
o t
ry
 th
em
, 
th
e t
re
atm
en
t w
ith
dr
aw
al 
tri
al,
 bu
t I
 th
in
k i
t’s
 st
ill
 pa
re
nt
s v
iew
s t
ha
t i
t’s
 no
t 
he
lp
in
g (
CA
M
HS
 7)
N/
A
Ph
ys
ica
l o
pp
or
tu
ni
ty
La
ck
 of
 ed
uc
at
ion
al 
m
at
er
ial
s a
bo
ut
 d
ru
g h
oli
da
ys
I d
on
’t 
ha
ve
 an
y m
ate
ria
l a
va
ila
bl
e b
ut
 I 
tel
l t
he
m
 to
 tr
y, 
sta
rt 
try
in
g t
hi
s t
he
 
we
ek
en
d fi
rst
, t
he
n t
ry
 it
 m
or
e f
or
, s
ay
 1 
we
ek
 or
 tw
o, 
or
 if
 ev
er
yt
hi
ng
 is
 ok
 
th
en
 tr
y i
t m
or
e a
nd
 se
e h
ow
 it
 go
es
 (C
AM
HS
 4)
Ti
m
e c
on
str
ain
t
Yo
u c
ou
ld
 al
wa
ys
 m
ak
e a
 ca
se
, I
 kn
ow
, s
ay
in
g, 
oh
, w
e s
ho
ul
d b
e i
nv
ol
ve
d m
or
e, 
bu
t I
 th
in
k t
he
 tr
ut
h i
s t
ha
t i
t’s
 di
ffi
cu
lt 
be
ca
us
e o
f t
he
 ti
m
e c
on
str
ain
t (
GP
 5)
I m
ea
n b
as
ica
lly
 m
y r
ol
e i
s t
o c
he
ck
, i
s e
ve
ry
th
in
g O
K?
 A
re
 yo
u s
til
l t
ak
in
g t
he
 
tab
let
s?
 A
re
 th
er
e i
ss
ue
s w
ith
 co
m
pl
ian
ce
? I
’ll
 ha
ve
 a 
10
 m
in
, p
er
 pa
tie
nt
 (G
P1
)
Re
fle
cti
ve
 m
ot
iv
ati
on
Pe
rc
eiv
in
g t
he
ir 
ro
le 
as
 to
 m
ak
e e
nq
ui
ry
 ab
ou
t d
ru
g h
oli
da
ys
 an
d 
em
po
we
r 
fa
m
ili
es
 to
 m
ak
e t
he
ir 
ow
n 
de
cis
ion
I, 
we
ll 
I s
ay
, I
 m
ea
n m
y w
ho
le 
lin
e i
s t
ha
t I
’m
 no
t t
he
re
 to
 sa
y y
ou
 ha
ve
 to
 do
 
th
is 
or
 yo
u d
on
’t 
ha
ve
 to
 do
 th
is,
 I’
m
 th
er
e t
o a
dv
ise
, g
ive
 in
fo
rm
ati
on
, s
up
-
po
rt 
wh
er
e p
os
sib
le.
 If
 a 
pa
re
nt
 sa
ys
, n
o w
ay
 am
 I 
go
in
g t
o h
av
e a
 br
ea
k,
 th
en
 
th
at 
is 
th
eir
 de
cis
io
n (
CA
M
HS
 1)
Un
ce
rta
in
ty
 ab
ou
t t
he
 b
en
efi
ts 
of
 d
ru
g h
oli
da
ys
So
 I 
do
n’t
 th
in
k a
 w
ith
dr
aw
al 
alw
ay
s i
s h
elp
fu
l. 
In
 m
an
y c
as
es
 th
e w
ith
dr
aw
al 
is 
no
t h
elp
fu
l, 
ye
ah
, s
o w
e h
av
e t
o b
e c
ar
ef
ul
 (C
AM
HS
 4)
I t
hi
nk
 th
at 
tw
o-
th
ird
s o
f t
he
 ch
ild
re
n o
n m
ed
ica
tio
n t
he
n e
nd
 up
 go
in
g b
ac
k o
n 
m
ed
ica
tio
n (
CA
M
HS
 5)
Di
sa
gr
ee
m
en
t w
ith
 th
e c
on
ten
t o
f t
he
 gu
id
eli
ne
s r
eg
ar
di
ng
 an
d 
pe
rc
eiv
in
g 
dr
ug
 h
oli
da
y m
or
e a
dv
isa
bl
e a
t o
ld
er
 ag
e
W
ell
 ye
ah
, I
 th
in
k,
 w
ell
 I 
th
in
k,
 ye
ah
, i
t’s
 ve
ry
 ra
re
ly
 co
ns
id
er
ed
 fo
r a
ny
bo
dy
 
yo
un
g, 
it’
s m
or
e, 
I t
hi
nk
, u
se
fu
l i
n t
ee
na
ge
rs…
So
 I 
th
in
k i
t’s
 ve
ry
 di
ffi
cu
lt 
fo
r a
 yo
un
g c
hi
ld
 to
 m
ak
e s
en
se
 of
 w
ith
dr
aw
in
g t
he
m
, I
 th
in
k i
t’s
 th
e p
ar
en
ts’
 
de
cis
io
n (
CA
M
HS
 2)
Vi
ew
in
g A
DH
D 
as
 a 
ch
ro
ni
c d
ise
as
e t
ha
t n
ee
d 
co
ns
ta
nt
 tr
ea
tm
en
t
It’
s a
n i
nt
er
es
tin
g o
ne
 is
n’t
 it
? B
ec
au
se
 if
 yo
u’v
e b
ee
n d
iag
no
se
d w
ith
 di
ab
ete
s 
yo
u d
on
’t 
ten
d t
o t
ak
e 2
 w
ee
ks
 off
 yo
ur
 in
su
lin
 an
d I
 ju
st 
so
rt 
of
, i
t’s
 in
ter
es
t-
in
g s
o I
 w
on
de
r w
he
re
 th
at 
id
ea
 ha
s c
om
e f
ro
m
 ab
ou
t w
hy
 w
e m
ig
ht
 w
ith
dr
aw
 
m
ed
ica
tio
n (
CA
M
HS
 7)
Pe
rc
eiv
in
g t
he
ir 
ro
le 
as
 li
m
ite
d 
to
 re
fer
ra
l a
nd
 co
nt
in
ue
 p
re
sc
rib
in
g
M
y r
ol
e I
 se
e a
s s
ig
np
os
tin
g, 
I’m
 no
t t
ra
in
ed
 in
 ch
ild
 ps
yc
hi
atr
y (
GP
2)
I t
hi
nk
, i
t’s
 no
t s
om
eth
in
g t
ha
t I
 w
ou
ld
 in
iti
ate
, o
f c
ou
rse
, b
ut
 m
y r
ol
e i
s t
o r
ep
ea
t 
pr
es
cr
ib
in
g (
GP
 6)
Re
lyi
ng
 h
ea
vil
y o
n 
sp
ec
ial
ist
s
W
e d
o w
ha
t w
e a
re
 to
ld
, d
o y
ou
 kn
ow
 w
ha
t I
 m
ea
n?
 It
’s,
 be
ca
us
e i
t’s
 su
ch
 a 
sp
e-
cia
lis
ed
 th
in
g a
nd
 I 
th
in
k,
 I 
di
dn
’t 
re
ce
ive
 th
at 
m
uc
h t
ra
in
in
g i
n i
t e
ith
er
 (G
P 
8)
No
, I
’m
 al
l, 
I’m
 w
ait
in
g f
or
 th
e i
ni
tia
tiv
e t
o c
om
e f
ro
m
 se
co
nd
ar
y c
ar
e (
GP
1)
Co
nc
er
ns
 ab
ou
t a
br
up
t w
ith
dr
aw
al 
sy
m
pt
om
s
I t
hi
nk
 th
e w
ith
dr
aw
al 
ha
s t
o b
e d
on
e s
lo
wl
y, 
ju
st 
lik
e a
n a
nt
id
ep
re
ss
an
t, 
wi
th
 
clo
se
 su
pe
rv
isi
on
 (G
P 
8)
 K. Ibrahim, P. Donyai 
1 3
unless they received specific training as expressed by the 
following GP:
We ought to have training sessions on, we’re talking 
about holidays and when to stop and when, so we can 
actually justify with evidence what we’re doing (GP 2).
2. Opportunity
Physical opportunity and social opportunity were identi-
fied as important barriers for both GPs and CAMHS practi-
tioners to implement and adopt the recommendations about 
planned drug holidays. Time constraint was a major barrier 
for GPs to consider planned drug holidays but it was not 
an issue for CAMHS practitioners. Regular reviews (every 
6 months) and long appointment slots allowed CAMHS 
practitioners to carry out a full detailed review and gave 
them the opportunity in theory to discuss planned drug holi-
days with families. In contrast, GPs reported that 10-min 
appointments were only enough to repeat the prescription 
but not to discuss in detail the idea of trying to withdraw 
medication. The following quote clarifies this barrier:
You could always make a case, I know, saying, oh, we 
should be involved more, but I think the truth is that 
it’s difficult because of the time constraint (GP 5).
When CAMHS practitioners discuss the idea of consid-
ering a break from ADHD medication, they do it verbally 
without the use of any other aids. There was no consensus 
guideline in relation to the information provided to families 
about ADHD drug holidays and so the discussions are left 
to the individual practitioner as illustrated in the following 
comment:
I don’t have any material available but I tell them to 
try, start trying this the weekend first, then try it more 
for, say one week or two, or if everything is ok then try 
it more and see how it goes (CAMHS 4)
Thus, the perspective of individual CAMHS practition-
ers and their perceptions towards drug holidays could pos-
sibly impact on the information provided to families and 
their acceptance. The decision of whether or not to take 
a planned break from medication is made by parents of 
children with ADHD, specifically with younger patients. 
CAMHS practitioners perceived their role was to discuss 
trying to stop the medication temporarily and to empower 
families to make the decision themselves. Negative paren-
tal perceptions towards drug holidays did not allow some 
CAMHS practitioners to further explore a planned drug 
holiday and others initiate weekend drug holidays without 
the practitioner’s recommendation as demonstrated in the 
following comments:
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Most of the parents don’t want to stop medication…
Do you want to try them, the treatment withdrawal 
trial, but I think it’s still parents views that it’s not 
helping (CAMHS 4)
CAMHS practitioners reported some reasons for paren-
tal rejection of planned drug holidays including worries 
about the child’s academic life, negative experiences with 
unintentional non-adherence accidents, fears of teachers’ 
complaints, parents’ inability (or fears of inability) to cope 
with their children without the medication, and worries of 
going back to the previous state before starting the medi-
cation. The following comment from one CAMHS practi-
tioner reflected this clearly:
Other parents just think, well no I’m going to go 
back to doing, they’re going to go back to being what 
they were before, without even trying to have a holi-
day break (CAMHS 6)
3. Motivation
Despite unawareness of specific recommendations 
about planned drug holidays, all GPs showed positive 
opinions towards the concept for a variety of reasons. 
Concerns about stimulants’ unknown long-term effects, 
especially on a child’s brain, made four GPs favour the 
idea of stopping the medication temporarily.
Well do they still need it? Why should I give medica-
tion which is unnecessary? Should we be doing that 
especially in children with growing brains and all 
this sort of thing? (GP 1)
In principle I think it’s a good idea, yes. You, ulti-
mately you would like all children with ADHD to be 
off medication if necessary, either because their con-
dition improves or medication is no longer needed 
(GP 3)
I think one needs to be aware of the side effects and, 
as I say, from my perspective, I’m always keen to 
try and withdraw any medication with children, par-
ticularly a medication like methylphenidate if one 
worries about what the effects might be (GP 5)
Planned drug holidays were seen by five GPs as an 
opportunity to identify children who might not need to 
take the medication anymore and avoid putting them on 
unnecessary medication which could possibly save NHS 
resources as reported by the following GP:
Well as I said, for me the instance is a psycho-stimu-
lant that works on the central nervous system, secondly 
the liver accumulates all the chemicals we put into it. 
Thirdly why prescribe when you don’t have to in terms 
of cost on NHS? (GP 2)
However, CAMHS practitioners showed varied percep-
tions. Five CAMHS practitioners had positive attitudes 
towards drug holidays and thought it was good practice to 
test the continuing need for medication. One CAMHS doc-
tor argued that the need for medication can’t be assessed 
unless medication is stopped ‘if you don’t stop you don’t 
know’, while three CAMHS practitioners questioned the 
need for implementing drug holidays and were less moti-
vated to actually exercise it. One viewed ADHD as a chronic 
disease similar to diabetes and hypertension that needs to be 
treated continuously. Others believed that the effectiveness 
of medication is well checked by parents either by intention-
ally taking a break from medication or unintentionally when 
forgetting to give the medication:
It’s an interesting one isn’t it? Because if you’ve been 
diagnosed with diabetes you don’t tend to take two 
weeks off your insulin and I just sort of, it’s interesting 
so I wonder where that idea has come from about why 
we might withdraw medication (CAMHS 7)
They (parents) are good checking it out themselves, 
they don’t need us to tell them when to try it. I 
think it’s, that’s my perception of why it’s happened 
(CAMHS 2)
Some CAMHS practitioners felt that a drug holiday is 
generally unhelpful and that most children with ADHD 
can’t function well without the medication. They expressed 
worries about the possible consequences of stopping the 
medication even temporarily on family life and the child’s 
academic achievements. Some disagreed with the guidelines 
requirements and argued that planned drug holidays were 
not preferable at younger age and more advisable among 
adolescents. They believed that these breaks could allow 
self-assessment of ability to manage without the medication 
as demonstrated below:
Somebody’s ten year old, and he started medication at 
eight year old, then obviously the psychological inter-
vention they may not be able to use it correctly. I don’t 
know but comparatively, compared to 10 years stop-
ping, compared to 14 years stopping, the medication 
is more needed (CAMHS 4)
The uptake of planned drug holidays from ADHD 
medication tied in with beliefs about perceived roles. GPs’ 
viewed ADHD a specialist area and perceived their role to be 
limited to initial referral of families for CAMHS assessment 
and later to continue/repeat prescription. They had concerns 
about the possibility that stopping stimulant medication 
abruptly could be associated with withdrawal effects which 
made them reluctant to initiate drug holidays themselves. 
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They believed that ADHD medication (specifically stimu-
lants) acts similar to antidepressants by interfering with 
dopamine and noradrenaline levels in the brain and could 
possibly have similar adverse events. They showed prefer-
ence that the initiative should come from the specialist and 
withdrawal needed to occur over slowly a prolonged period. 
However, abrupt withdrawal of ADHD medication was not 
a concern for CAMHS practitioners who believed that the 
medication is either in or out of the body system:
I would be reluctant to withdraw it without advice 
from the consultant. Yes, if you withdraw a stimulant 
abruptly then clearly there could be withdrawal effects 
from it and you would want to manage those (GP 3)
Discussion
Using the COM-B model allowed identification and under-
standing of the barriers that impact on the practice of 
planned practitioner-initiated drug holidays. CAMHS prac-
titioners appeared to have the capability to initiate planned 
drug holidays, whereas lack of knowledge and skills about 
ADHD in general and specifically about drug holidays was 
a vital barrier for GPs. Opportunity was a main barrier for 
both groups. Time constraint, parental disinclination to stop 
medicating their children, and lack of educational/informa-
tion resources about ADHD drug holidays were all reported 
as potential barriers. Motivation was more complex to define 
for both CAMHS practitioners and GPs. CAMHS practition-
ers were less motivated to initiate planned drug holidays 
and some felt families should be empowered to make such 
a decision. However, GPs were more motivated due to wor-
ries about long-term medication side effects as well as cost 
savings but felt uncomfortable to withdraw the medication 
themselves.
GPs lacked motivation and capability to initiate them-
selves a break from medication due to lack of knowledge 
and training about ADHD in general and drug holidays in 
specific. Several studies worldwide have reported inad-
equate knowledge of GPs about ADHD and its treatment 
(Ghanizadeh and Zarei 2010; Jawaid et al. 2008; Lian et al. 
2003; Louw et al. 2009; Shaw et al. 2003; Salt et al. 2005). 
GPs elsewhere have also expressed low levels of interest 
in becoming highly involved in ADHD care (Shaw et al. 
2003; Salt et al. 2005). Thus, ‘education’ and ‘enablement’ 
interventions designed to improve the knowledge and skills 
of GPs about ADHD, its management, and how to with-
draw the medication could increase their confidence in 
their abilities to manage children with ADHD and could 
motivate them to engage more in discussions about drug 
holidays with families of children with ADHD. Educational 
outreach visits, whereby trainers visit clinicians where they 
practise and provide them with information to change how 
they practise, are reported to improve the delivered care for 
patients (O’Brien et al. 2007). A Cochrane review found that 
interactive training results in moderately large changes in 
professional practice (Forsetlund et al. 2009).
Incentivisation also could be a possible intervention to 
target lack of GPs’ involvement. Some of the GPs inter-
viewed in this study reported that he would consider dis-
cussing and undertaking planned drug holiday from ADHD 
medication if they were to receive incentives. However, as 
shown earlier, incentivisation interventions (the Commis-
sioning for Quality and Innovation CQUIN incentives) were 
not thought by CAMHS practitioners to increase the uptake 
of practitioner-initiated drug holidays. Setting up an ADHD 
clinic in GP practices to review and manage children and 
adolescents with ADHD was also suggested as a way to 
engage GPs more in the management of ADHD including 
the consideration of drug holidays.
Findings indicated a possible connection between lack 
of uptake of practitioner-initiated drug holidays and lack of 
resources about ADHD drug holidays for patients or par-
ents to use (physical opportunity) and to address parents’ 
concerns (social opportunity). Discussions, which happened 
within secondary care, took the shape of verbal communica-
tion that might reflect an individual practitioner’s attitudes 
and views about drug holidays. Decision-making models 
are becoming increasingly important in attempts to increase 
engagement of patients and their families as partners in their 
care (Légaré et al. 2008). A Cochrane review reported that 
decision aids could increase patient’s involvement and were 
more likely to lead to informed values-based decisions (Sta-
cey et al. 2014). Another systematic review has shown that 
decision aids improve knowledge, reduce decisional conflict, 
and stimulate patients to be more active in decision making 
without increasing their anxiety (O’Connor et al. 1999). Spe-
cifically in ADHD, a study examined the effect of a shared 
decision-making intervention with parents of children newly 
diagnosed with ADHD and found that parents were better 
informed about treatment options without increasing visit 
duration (Brinkman et al. 2013).
The degree of shared decision making between families 
of children with ADHD and consultants varied across stud-
ies (Brinkman et al. 2011; Fiks et al. 2010). A study exam-
ined the views of parents and clinicians towards shared deci-
sion making and reported that both had favourable opinions 
(Fiks et al. 2010). Parents described the process as a part-
nership between equals, with physicians providing medical 
expertise, and the family contributing in-depth knowledge of 
the child. In contrast, clinicians understood shared decision 
making as a means to encourage families to accept clini-
cians’ preferred treatment (Fiks et al. 2011). Therefore, it is 
important to give families of children with ADHD full bal-
anced information about the advantages and disadvantages 
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of considering planned drug holidays to make their own 
decisions. Therefore, designing a decision aid about ADHD 
drug holidays could be a useful tool to help both practi-
tioners and families to have a productive discussion, avoid 
practitioners’ bias, address parents’ anxiety towards stopping 
the medication and allow informed decisions to be made in 
relation to drug holidays in ADHD.
Practical recommendations for successful drug 
holidays
Practitioners who took part in this study talked about the 
timing, length and most suitable cases for drug holidays to 
test the continued need for medications as demonstrated in 
the following recommendations:
1. Timing The best time to interrupt the medication is over 
the school holidays (often over the summer holidays). 
Stressful times such as Christmas, when the family 
is distressed for any reason, and the beginning of any 
school year, especially at the start of junior/senior high 
school should be avoided. However, parents should be 
given the choice on whether they prefer to involve the 
school in assessing how the child is without medication 
at school.
2. Length Drug holidays should be at least 1 week long and 
continue as long as child behaviour is manageable.
3. Frequency Drug holidays should be offered first after 
being on medication for 2 years and then at least on an 
annual basis.
4. Best age Independent of age, the indication for medi-
cation continuation should be assessed annually within 
a drug treatment-free period. However, drug holidays 
are more advisable among older children because they 
are able to use psychological interventions during the 
breaks, they can self-assess their abilities to cope with-
out the medication, they may not need medication any-
more due to the development of executive functions.
5. Decision making The decision on whether or not to take 
a drug holiday should be a shared decision that empow-
ers and takes into account parents’ and patients’ choices 
and involves them fully.
6. Sudden or abruptly stopping Stimulant medication such 
as methylphenidate can be stopped abruptly without the 
need to gradually decrease the dose.
7. Follow-up and monitoring The assessment of the impact 
of drug holidays on children’s behaviour and abilities to 
concentrate should involve feedback from parents and 
their children as well as close follow-up by practitioners 
who may choose to use an objective measure to assess 
the usefulness of drug holidays.
8. Most successful cases
• Drug holidays are more successful among stable 
cases where the child is symptom-free for a reason-
able period of time.
• Drug holidays should be offered to everyone regard-
less of their type of diagnosis (i.e. hyperactive/
impulsive type, inattention type, and combined type).
• Drug holidays are more successful when there is an 
agreement between the child and their parents about 
having a trial without the medication and where the 
surrounding environments (such as family members 
and school teachers) are supportive.
• Drug holidays might be more successful among chil-
dren who are on a low dose of medication or those 
who don’t have other comorbidities (such as autistic 
syndrome or obsessive–compulsive disorder).
Strengths and limitations
This was the first study that examined in a qualitative and 
systematic way the barriers, from practitioners’ point of 
view, for the discussion of formal drug holidays from ADHD 
medication in children and adolescents. Bearing in mind the 
potential benefits of taking breaks from ADHD medication 
on managing side effects and testing continuing need, we 
discussed a number of interventions that could possibly 
increase at least discussions about planned drug holidays 
if not undertaking them. However, the experience of drug 
holidays from ADHD medication was examined among 
practitioners based in one English County. Although similar 
shared-care arrangements are developed in other UK coun-
ties, the findings might not fully represent the perceptions 
and experiences of other practitioners inside or outside the 
UK. This study was not designed for the purpose of iden-
tifying a protocol or to give recommendations for how to 
implement a ADHD drug holidays. More research is needed 
specifically to draw a consensus among health professionals 
about how to implement successful drug holidays to test the 
continued need for medication.
Future research
Future research should focus on designing education and 
training interventions and examining how they could be 
operationalised in primary care to increase GPs’ involvement 
in shared-care of children with ADHD and enforce their 
capabilities to discuss and plan drug holidays. Moreover, 
future research should focus on designing decision aid(s) 
about drug holidays that could provide practitioners with the 
opportunity to discuss planned drug holidays with families 
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and allow parents and their children to make informed deci-
sions on whether or not to try drug holidays.
Conclusions
Using an evidence-based methodology, possible barriers to 
the discussion and uptake of formal drug holidays as rec-
ommended by guidelines for the purpose of assessing the 
continued need for ADHD medication were identified and 
opportunities do exist for improving engagement. A number 
of interventions could be used including training and edu-
cating GPs about ADHD and employing a decision-making 
tool that could help families make an informed decision on 
whether or not to consider drug holidays. The implemen-
tation of decision aids about ADHD drug holidays could 
have cost-effective implications for the NHS by helping to 
save resources via stopping the prescribing of unnecessary 
medication. The findings presented here have the potential to 
aid practitioners and policy makers to routinely recommend 
and support planned breaks from ADHD medication during 
the school holidays to test continuing need for medication.
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